Evidence map›Paper›PMID 36542694›Full record

ArticleScience translational medicine2022

Persistent post-COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium.

John B Finlay, David H Brann, Ralph Abi Hachem, David W Jang, Allison D Oliva, Tiffany Ko, Rupali Gupta, Sebastian A Wellford, E Ashley Moseman, Sophie S Jang and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Science translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 5 pooled it
17.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 5 syntheses or guidelines pooled it, 144 citations in OpenAlex.

  1. Therapeutic effect of anti-neuroinflammatory supplement combined with olfactory training on post-covid olfactory dysfunction: a systematic review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Pooled it
  2. Pooled it
  3. Mucosal immune response in biology, disease prevention and treatment.Signal transduction and targeted therapy · 2025
    Pooled it
  4. Pathophysiological Mechanisms in Long COVID: A Mixed Method Systematic Review.International journal of environmental research and public health · 2024
    Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Unique nasal cell states induced by common pediatric respiratory viruses.bioRxiv : the preprint server for biology · 2026
    Article
  20. Olfactory immunity: defending the neural-mucosal barrier.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

John B FinlayMedical Scientist Training Program, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-3038-1276
David H BrannDepartment of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-8844-8886
Ralph Abi HachemDepartment of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, NC 27710, USA.
David W JangDepartment of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, NC 27710, USA.
Allison D OlivaDepartment of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, NC 27710, USA.
Tiffany KoDepartment of Neurobiology, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-5006-6345
Rupali GuptaDepartment of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0003-0527-2200
Sebastian A WellfordDepartment of Immunology, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-2535-6893
E Ashley MosemanDepartment of Immunology, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-6064-6116
Sophie S JangDepartment of Otolaryngology-Head and Neck Surgery, University of California San Diego, San Diego, CA 92037, USA.ORCID 0000-0002-8074-5058
Carol H YanDepartment of Otolaryngology-Head and Neck Surgery, University of California San Diego, San Diego, CA 92037, USA.ORCID 0000-0003-1934-4922
Hiroaki MatsunamiDepartment of Neurobiology, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-8850-2608
Tatsuya TsukaharaDepartment of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-6928-8562
Sandeep Robert DattaDepartment of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-8068-3862
Bradley J GoldsteinDepartment of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-9612-1696
Duke University · USHarvard University · USUniversity of California San Diego · US

Funding

Basic Immunology Training ProgramT32AI052077 · NIAID · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 2002 to 2024
$4.2M
Characterizing the Functional Architecture of the Necklace Olfactory SystemR01DC016222 · NIDCD · HARVARD MEDICAL SCHOOL · PI DATTA, SANDEEP R · 2017 to 2021
$2.8M
Therapeutic potential for modulation of olfactory basal stem cellsR01DC016859 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GOLDSTEIN, BRADLEY J · 2018 to 2022
$2.2M
Treatment of Primary Amoebic Meningoencephalitis via Modulation of Antibody Effector FunctionsR01NS121067 · NINDS · DUKE UNIVERSITY · PI MOSEMAN, E. ASHLEY · 2021 to 2025
$2.0M
Elucidating Olfactory Epithelial Anti-Viral Responses in Persistent Post-Viral Olfactory DysfunctionK08DC019956 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Carol H Yan · 2022 to 2026
$959k
Single cell analysis of human olfactory mucosaR21DC018371 · NIDCD · DUKE UNIVERSITY · PI GOLDSTEIN, BRADLEY J · 2020 to 2021
$443k
Infectious Influence: Using fate mapping to determine the impact of viral infection sites on Alzheimer's disease initiationR21AG074324 · NIA · DUKE UNIVERSITY · PI MOSEMAN, E. ASHLEY · 2021 to 2022
$439k
NIAID NIH HHS T32 AI052077NIA NIH HHS R21 AG074324NIDCD NIH HHS K08 DC019956NIDCD NIH HHS R01 DC016222NIDCD NIH HHS R01 DC016859NIDCD NIH HHS R21 DC018371NINDS NIH HHS R01 NS121067
6 · The paper itself

Abstract

SARS-CoV-2 causes profound changes in the sense of smell, including total smell loss. Although these alterations are often transient, many patients with COVID-19 exhibit olfactory dysfunction that lasts months to years. Although animal and human autopsy studies have suggested mechanisms driving acute anosmia, it remains unclear how SARS-CoV-2 causes persistent smell loss in a subset of patients. To address this question, we analyzed olfactory epithelial samples collected from 24 biopsies, including from nine patients with objectively quantified long-term smell loss after COVID-19. This biopsy-based approach revealed a diffuse infiltrate of T cells expressing interferon-γ and a shift in myeloid cell population composition, including enrichment of CD207

Indexed as

COVID-19Olfaction DisordersAnimalsAnosmiaGene ExpressionHumansOlfactory MucosaRNA, ViralSARS-CoV-2RNA, Viral

Identifiers

PMID36542694
PMCPMC10317309
OpenAlexW4312113379

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.